‘Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History’, published in Q1 2020 and co-authored by Dmitry Kaminskiy and Margaretta Colangelo, distilled the complex assembly of deep market intelligence and industry knowledge that Deep Knowledge Group and its Longevity-focused subsidiaries (including Longevity.Capital and Aging Analytics Agency) have developed over the past 7 years into a full-scope understanding of the global Longevity Industry.
The consortium’s work towards defining the Longevity Industry, and in creating and disclosing their frameworks for tangible analysis, systematization and forecasting of the industry in order to optimize our own strategic decision making in this domain, remains as important today as every before. Despite the fact that the Longevity Industry has witnessed unprecedented levels of growth and maturation over the past decade, the term Longevity itself, still remains unclear to many people (and to investors in particular) associate Longevity with such topics as typical anti-aging skin creams and the fitness and wellness industries.
In reality, Longevity is the deepest of all DeepTech sectors, and occupies the very forefront of advanced biomedicine, sitting at the intersection of many domains of DeepTech and Frontier Technologies. The industry’s intersection with, and reliance upon, advanced technologies does not, however, exclude or preclude the fact that it is also deeply interconnected with specific behavioural and lifestyle interventions. What it does mean, however, is that the scope and sophistication of technology-based tools and methods of optimizing day-to-day Healthy Longevity are large, rapidly increasing, and much broader (and deeper) than many people may realize, extending far beyond simplistic approaches involving diet, exercise and supplements, encompassing DeepTech products and services that are becoming increasingly available to the consumer.
Our first book, 'Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History' devoted one of its four sections to the topic of Longevity Policy and Governance, and the future rise of Longevity Politics. Now, in 2021, that time has come, as increasing numbers of governments are begin to formulate and execute national industrial strategies to facilitate the synergetic development of four main sectors and driving forces of Longevity Industrialization (Advanced Biomedicine, AgeTech, Artificial Intelligence (AI), and the Longevity Financial Industry), with the goal of transforming the challenge of aging population into the opportunity of Healthy Longevity, and to prioritize the concept of Longevity from both a population health and an industrialization standpoint.
Developments in this arena are accelerating to such an extent that an entire book is now necessitated to gain an actionable, deep and comprehensive understanding of the challenges and opportunities at play on the new frontier of Longevity Governance. In ‘Longevity Politics: Longevity Technocracy, Modern Approaches to Policy, Governance & National Industrial Strategies, and Longevity as the New Political Priority of the 21st Century’, Dmitry Kaminskiy charts the rise of progressive Longevity MegaHubs and Technocracies, the concept of the Longevity Valley and its evolution toward the Longevity State, global benchmarking of national and local Longevity Industrial Strategies, international benchmarking of National Healthy Longevity, Longevity Ethics (how potential negative societal outcomes resulting from Longevity can be proactively optimized to ensure maximized socioeconomic benefit), and how Longevity will become central, essential and fundamental to developed nations’ political agendas by 2030.
Whereas Longevity Industry 1.0 charted the inception and rise of the industry up to 2020, and provided the methodology and framework for defining and analyzing the industry, its sequel, ‘Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity - The Blueprint and Pathway from Longevity Industry 1.0 to 2.0’, outlines Deep Knowledge Group’s recent and ongoing work towards formulating the pathway to Longevity Industry 2.0, and presents the framework for safeguarding the sector’s current upward trajectory and ensuring its optimized, sustainable growth towards its next stage and the realization of its practical benefits for humanity by the year 2030.
The book outlines several issues (and proposed solutions) that we believe constitute the foremost bottlenecks and risks to a continuing, positive trajectory of development in Longevity science, policy, industry, finance and investment, and present a preliminary preview of the frameworks we are developing to help strategic decision makers, industry participants and the general public take greater control over the actual, real-world development of both the Longevity Industry and Healthy Human Longevity.
Meanwhile, the next book in the series, ‘Longevity Industry 3.0: Stable Acceleration of Longevity Industrialization to Achieve its Practical Humanitarian Impact by the Year 2027’, will present the framework and toolsets required to maximize the positive societal benefits and neutralize the potentially detrimental consequences of Longevity, and how to accelerate its major practical impacts (including economic growth and stabilization and additional socially-inclusive HALE and QALY-years for humanity ahead of standard timelines - not in 10 years, but in 7.
About the Author
Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.
Mr. Kaminskiy is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.
He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.
He is a frequent speaker on the topics of AI and Longevity, including conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities.
Mr. Kaminskiy serves as managing trustee of Biogerontology Research Foundation, the UK’s oldest Longevity focused charity, and Head of International Development of the Longevity International UK - the Secretariat for the UK All-Party Parliamentary Group for Longevity, the world’s first official parliamentary group specifically dedicated to Longevity.